Variant report
Variant | nsv968140 |
---|---|
Chromosome Location | chr5:14648902-14653282 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:10)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:10 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:14366799..14367387-chr5:14648407..14648919,2 | K562 | blood: | |
2 | chr5:14108776..14109307-chr5:14648451..14649059,2 | K562 | blood: | |
3 | chr5:14364046..14364977-chr5:14648428..14649312,3 | K562 | blood: | |
4 | chr5:14398708..14399914-chr5:14648355..14649288,5 | MCF-7 | breast: | |
5 | chr5:14352294..14352920-chr5:14648683..14649276,2 | MCF-7 | breast: | |
6 | chr5:13976771..13977506-chr5:14648421..14648943,2 | MCF-7 | breast: | |
7 | chr5:14352118..14352949-chr5:14648765..14649375,3 | K562 | blood: | |
8 | chr5:14363978..14364976-chr5:14648837..14649345,2 | MCF-7 | breast: | |
9 | chr5:13987663..13988894-chr5:14648405..14649724,6 | K562 | blood: | |
10 | chr5:14405228..14405866-chr5:14648409..14649049,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000038382 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs572104768 | chr5:14648906-14648907 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs77497098 | chr5:14648950-14648951 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs149497 | chr5:14648974-14648975 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs370711376 | chr5:14649000-14649001 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs152718 | chr5:14649033-14649034 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs552077179 | chr5:14649095-14649096 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs531438818 | chr5:14649120-14649121 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs570671453 | chr5:14649166-14649167 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs568437426 | chr5:14649182-14649183 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs561959018 | chr5:14649187-14649188 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs62344876 | chr5:14649188-14649189 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs557566969 | chr5:14649206-14649207 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs547317568 | chr5:14649220-14649221 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs565625333 | chr5:14649267-14649268 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs533026574 | chr5:14649297-14649298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181508236 | chr5:14649360-14649361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570713073 | chr5:14649371-14649372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs374632447 | chr5:14649386-14649387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs76209877 | chr5:14649440-14649441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs556376970 | chr5:14649446-14649447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs568663884 | chr5:14649457-14649458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs569275355 | chr5:14649470-14649471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs536041456 | chr5:14649476-14649477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs116485114 | chr5:14649571-14649572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572799019 | chr5:14649585-14649586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147196357 | chr5:14649589-14649590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs202199895 | chr5:14649693-14649694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs34192990 | chr5:14649695-14649696 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs367997513 | chr5:14649696-14649697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs152759 | chr5:14649702-14649703 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs112524890 | chr5:14649714-14649715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs201512396 | chr5:14649760-14649761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs113576682 | chr5:14649782-14649783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs373692279 | chr5:14649808-14649809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs543551393 | chr5:14649858-14649859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs561606561 | chr5:14649911-14649912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs537726371 | chr5:14649940-14649941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540582163 | chr5:14649941-14649942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs562057991 | chr5:14649972-14649973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs145282763 | chr5:14649977-14649978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs559096841 | chr5:14649980-14649981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs533063381 | chr5:14650003-14650004 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551374237 | chr5:14650021-14650022 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs564548358 | chr5:14650025-14650026 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs531583675 | chr5:14650159-14650160 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs200171000 | chr5:14650197-14650198 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs550281097 | chr5:14650200-14650201 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs11551878 | chr5:14650226-14650227 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs568583896 | chr5:14650230-14650231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs12658605 | chr5:14650233-14650234 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cervical squamous cell carcinoma | 21590768 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cri-du chat syndrome | 16773131 | CNVD |
Cryptorchidism | 21048976 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cervical cancer | 16585170 | CNVD |
Mental retardation | 16773131 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Cri-du chat syndrome | 22470819 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Schizophrenia | 18940311 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Mental retardation | 17847001 | CNVD |
Neurocytoma | 17123091 | CNVD |
Mental retardation | 19546859 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 21611746 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:14647600-14649200 | Enhancers | NHLF | lung |
2 | chr5:14648600-14649000 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
3 | chr5:14648800-14650000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr5:14648800-14655200 | Weak transcription | Primary T killer naive cells fromperipheralblood | blood |
5 | chr5:14650000-14650600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |